Course Information

46th Annual UCLA State-of-the-Art Urology Conference

Live Virtual Learning

March 05, 2021 to March 06, 2021

Download: [ PDF ]

This course explores the most challenging management problems facing the practicing urologist. Distinguished faculty present current information and techniques in urologic oncology (prostate, bladder, kidney, testis), male and female voiding dysfunction and incontinence, urethral stricture disease, urinary tract infections and antibiotics, renal and ureteral stones, post-prostatectomy impotence, priapism, anorgasmia, prostate cancer focal and radiation therapy, genetic testing, advanced prostate cancer therapy, robotic surgery, BCG shortage and bladder cancer, and management of bilateral and multifocal renal tumors. The conference emphasizes interaction between participants and faculty and allows ample time for case presentations and group discussions, ensuring an outstanding educational experience for attendees.

Enrollment

To enroll click here.

*Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at midnight on Tuesday, March 2nd.

Enrollment after online registration has closed: Please call (310) 794 – 2620 between 8:00 AM – 5:00 PM (Pacific Standard Time) by Thursday, March 4th and leave a voicemail with your name, callback number, and the course you’d like to attend. Our staff will return your call during business hours.

Enrollment on the day(s) of the course: Registration will only be accepted between 7:00 AM - 10:00 AM (Pacific Standard Time). Please leave a voicemail with your name, callback number, and the course you’d like to attend. An assistant will return your call during that timeframe to enroll you in the course.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620.

By Fax

Send the completed enrollment form with credit card information and authorizing signature to the Office of Continuing Medical Education at (310) 794-2624.

Course Fee

  • $175.00

Refunds

Cancellations must be received in writing by Friday, February 19, 2021 and will be subject to a $75 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.

Course Faculty

Guest Faculty
Arthur L. Burnett, MD, MBA
Patrick C. Walsh Distinguished Professor of Urology, Oncology
The Brady Urological Institute Department of Urology
Johns Hopkins Medical Institutions
Baltimore, Maryland

Sam S. Chang, MD, MBA
Patricia and Rodes Hart Professor of Urologic Surgery
Vanderbilt University Medical Center
Chief Surgical Officer
Vanderbilt Ingram Cancer Center
Nashville, Tennessee

Ralph V. Clayman, MD
Distinguished Professor/Endowed Chair in Endourology
Dean – Emeritus
University of California, Irvine
Department of Urology
Orange, California

Scott Eggener, MD
Professor of Surgery
University of Chicago
Chicago, Illinois

Kathleen C. Kobashi, MD, FACS
Head, Section of Urology and Renal Transplantation
Virginia Mason Medical Center
Seattle, Washington

Kurt A. McCammon, MD
Devine Chair in Genitourinary Reconstructive Surgery
Chairman and Program Director
Professor Department of Urology
Eastern Virginia Medical School
Norfolk, Virginia

Daniel E. Spratt, MD
Professor of Radiation Oncology
Laurie Snow Endowed Research Professor
Associate Chair, Clinical Research
Chair, Genitourinary Clinical Research, Rogel Cancer Center
University of Michigan
Ann Arbor, Michigan

Course Chair
William J. Aronson, MD

Course Co-Chairs
Craig Canfield, MD
Karim Chamie, MD, MSHS






 

Department of Urology Faculty*
Mark S. Litwin, MD, MPH
Professor and Chair
Department of Urology
Professor of Health Policy and Management
School of Public Health

A. Lenore Ackerman, MD, PhD
William J. Aronson, MD
Z. Chad Baxter, MD
Karim Chamie, MD, MSHS
Arnold I. Chin, MD, PhD
Matthew Dunn, MD
Sriram Eleswarapu, MD, PhD
Stanley Frencher, Jr., MD, MPH
Ja-Hong Kim, MD
Leonard S. Marks, MD
Jesse N. Mills, MD
Victor W. Nitti, MD
Allan J. Pantuck, MD, MS
Jacob Rajfer, MD
Robert E. Reiter, MD, MBA
Christopher S. Saigal, MD, MPH
Kymora Scotland, MD
Brian Shuch, MD, PhD

UCLA Faculty*
Alexandra Drakaki, MD, PhD
Assistant Professor of Medicine and Urology
Director, Genitourinary Medical Oncology Program
Co-Director of Research, GU Trials Program
Division of Hematology
Oncology and Institute of Urologic Oncology

Amar U. Kishan, MD
Assistant Professor
Chief of Genitourinary Oncology Service
Vice Chair of Clinical and Translational Research
Department of Radiation Oncology

Sandy T. Liu, MD
Division of Hematology-Oncology
Department of Medicine
Institute of Urologic Oncology
Department of Urology

Siddharth A. Padia, MD
Professor of Interventional Radiology
Director, IR at UCLA Santa Monica Hospital

Matthew Rettig, MD
Professor of Medicine and Urology
Medical Director, Prostate Cancer Program Institute of Urologic Oncology
Associate Director, Hematology-Oncology Fellowship Program
Chief, Division of Hematology-Oncology
VA Greater Los Angeles – West Los Angeles

Huihui Ye, MD
Chief of Genitourinary Pathology
Associate Professor, Department of Pathology

*David Geffen School of Medicine at UCLA
 

Virtual Exhibitor Room (Non-CME) ǂ

Attendees will have the opportunity to visit virtual commercial exhibits prior to the start of the CME program and during breaks. This portion of the program is not accredited for CME credit.

 

Friday, March 5, 2021

7:55 am (PST) Introductions and Announcements
William J. Aronson, MD
Male and Female Voiding Dysfunction, Reconstruction, Urethral Stricture Disease
Moderator: Victor W. Nitti, MD
8:00 am Evaluation and Treatment of Mixed Urinary Incontinence in Women 2021
Victor W. Nitti, MD
8:20 am Tips on 3rd Line Therapies for Overactive Bladder – Videos Included
Kathleen C. Kobashi, MD, FACS
8:40 am Evaluation and Management of Recurrent UTI’s in Women
Kathleen C. Kobashi, MD, FACS
9:00 am Value of Genetic Testing and Next Generation Sequencing in Diagnosis of UTI
A. Lenore Ackerman, MD, PhD
9:10 am Panel Discussion: Voiding Dysfunction and UTI’s in Women
Audience Questions – Case Presentations
Moderator: Dr. Ja-Hong Kim
Panel: Drs. Ackerman, Baxter, Kobashi, and Nitti
9:50 am Break & Visit Virtual Exhibitor Room (Non-CME) ǂ
10:10 am Management of Urethral Stricture Disease in 2021: Dilation, Incision, Reconstruction
Kurt A. McCammon, MD
10:30 am Underactive Bladder and Bladder Outlet Obstruction in Men: Is Surgery Indicated?
Victor W. Nitti, MD
10:50 am Are Male Slings a Good Option for Mild and Moderate Stress Incontinence in Men?
Kurt A. McCammon, MD
11:10 am Panel Discussion: Male Voiding Dysfunction
Audience Questions – Case Presentations
Moderator: Dr. Victor W. Nitti
Panel: Drs. Baxter, Kim, Kobashi, and McCammon
12:00 pm Break & Visit Virtual Exhibitor Room (Non-CME) ǂ
Urolithiasis/Endourology
Moderator: Matthew Dunn, MD
1:00 pm Metabolic Evaluation and Medical Management of Urolithiasis: A Simplified Approach (Stone Tree)
Ralph V. Clayman, MD
1:20 pm Update on Antibiotic Use and Management of Pre and Postop Infections in Endoscopic Surgery
Matthew Dunn, MD
1:35 pm Death of the PCNL: Increasing Utilization of Ureteroscopy Now and in the Future
Ralph V. Clayman, MD
1:55 pm Ureteral Stents – A Love/Hate Relationship
Kymora Scotland, MD
2:10 pm Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Matthew Dunn
Panel: Drs. Clayman and Scotland
3:00 pm Break & Visit Virtual Exhibitor Room (Non-CME) ǂ
Men’s Health – Penile Rehab, Priapism, Anorgasmia
Moderator: Jacob Rajfer, MD
3:20 pm Rehab of the Penis Post-Prostatectomy – The Hopkins Experience
Arthur L. Burnett, MD, MBA
3:40 pm How and Why to Set Up a Men’s Health Clinic
Jesse N. Mills, MD
3:55 pm Medical and Surgical Approaches to Priapism
Arthur L. Burnett, MD, MBA
4:15 pm Anorgasmia: What, Why, and How to Treat
Sriram Eleswarapu, MD, PhD
4:30 pm Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Jacob Rajfer
Panel: Drs. Burnett, Eleswarapu and Mills
5:45 pm Adjourn

Saturday, March 6, 2021

6:30 am (PST) Visit Virtual Exhibitor Room (Non-CME) ǂ
7:00 am Single Port Robotic Surgery – Does This Advance our Field?
Arnold I. Chin, MD, PhD
7:30 am Robotic Radical Prostatectomy – Techniques for Optimizing Continence, Potency, and Negative Margins
Robert E. Reiter, MD, MBA
Prostate Cancer
Moderator: Mark S. Litwin, MD, MPH
8:00 am 10 Debunked Myths About Prostate Cancer
Scott Eggener, MD
8:20 am Improving the Quality of Decision Making in Prostate Cancer Using Shared Decision Making
Christopher S. Saigal, MD, MPH
8:35 am Personalizing Adjuvant vs. Early Salvage Radiotherapy
Daniel E. Spratt, MD
8:55 am Focal Therapy for Prostate Cancer – State of the Art
Scott Eggener, MD
9:10 am Active Surveillance in 2021: Update on Intensity of Follow Up and Inclusion of 3+4 Disease
Leonard S. Marks, MD
9:25 am Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Reiter, Saigal, and Spratt
9:55 am Break & Visit Virtual Exhibitor Room (Non-CME) ǂ
10:15 am Personalizing Hormone Therapy With Radiation Therapy Role for Biomarkers
Daniel E. Spratt, MD
10:30 am Management of Oligometastatic Disease in the World of PSMA Imaging
Robert E. Reiter, MD, MBA
10:50 am Update on Therapy for Advanced Prostate Cancer - Integrating Genetic Testing
Matthew Rettig, MD
11:10 am Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Rettig, Reiter, and Spratt
12:00 pm Break & Visit Virtual Exhibitor Room (Non-CME) ǂ
Bladder Cancer
Moderator: Mark S. Litwin, MD, MPH
1:00 pm New Advances in Bladder Cancer in 2021
Karim Chamie, MD, MSHS
1:15 pm Updates for Non-Muscle Invasive Bladder Cancer During BCG Shortage
Sam S. Chang, MD, MBA
1:30 pm Advances in Upper Tract Urothelial Cancer
Sam S. Chang, MD, MBA
1:45 pm Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Chamie, Chang, Chin, Drakaki, and Kishan
2:30 pm Break & Visit Virtual Exhibitor Room (Non-CME) ǂ
Testis Cancer
Moderator: Stanley K. Frencher, Jr., MD, MPH
2:50 pm Everything a Urologist Needs to Know About Testis Cancer
Scott Eggener, MD
3:10 pm Panel Discussion - Audience Questions - Case Presentations
Moderator: Dr. Stanley K. Frencher, Jr.
Panel: Drs. Eggener, Drakaki, and Litwin
Kidney Cancer
Moderator: Brian Shuch, MD
3:30 pm Role for Elective Radical Nephrectomy for T1B/T2A Renal Tumors
Brian Shuch, MD
3:45 pm Management Considerations for Bilateral/Multifocal Renal Tumors
Brian Shuch, MD
4:05 pm Panel Discussion and Case Presentations
Moderator: Dr. Brian Shuch
Panel: Drs. Chamie, Liu, Padia, Pantuck and Ye
5:40 pm Closing Remarks
William J. Aronson, MD
5:45 pm Adjourn

At the completion of this program, participants should be better able to:

  • Manage prostate cancer patients with active surveillance
  • Utilize molecular markers for personalizing prostate cancer care
  • Counsel patients on focal therapy for prostate cancer
  • Utilize PSMA imaging for managing patients with oligometastatic prostate cancer
  • Manage bladder cancer patients in the era of BCG shortages
  • Manage patients with upper tract urothelial cancer
  • Manage bilateral and multifocal renal tumors
  • Treat patients with testis cancer
  • Manage male and female voiding dysfunction
  • Utilize male slings for post-prostatectomy incontinence
  • Manage patients with kidney and ureteral stones
  • Treat patients with priapism
  • Utilize strategies for post-prostatectomy penile rehabilitation
  • Understand and treat anorgasmia
  • Understand the therapies for advanced prostate cancer and role for genetic testing
  • Manage recurrent UTI’s in women and utilize genetic testing for UTI diagnosis
  • Manage urethral stricture disease
  • Carry out a metabolic evaluation for urolithiasis
  • Improve shared decision making in patients with prostate cancer

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 17 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

American Society of Radiologic Technologists (ASRT) Credit

Approved by the ASRT for a maximum of 15 Category A continuing education credit.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.